Organisation

Organisation name

NPOJORTC
Japanese Organisation for Research and Treatment of Cancer

The director general

Dr. Masahiro Tsuboi, MD, PhD.
Division of Thoracic Surgery, National Cancer Center East Hospital

Location/Contact

Address:302,2-54-6,Nishinippori,Arakawa-ku,Tokyo,JAPAN
TEL:03-5604-9850 FAX:03-5604-9851 E-mail:info@jortc.jp

Organisation Chart

Aim

JORTC aims for the establishment of standard cancer treatment and its propagation which lead to the promotion for health, medical, and welfare systems. JORTC undertakes affairs to support physicians and researchers in conducting clinical trials, including support for protocol-writing, data management and statistical consideration to maintain and guarantee the quality of clinical trials, and organizing and operating a third-party supervisory /management system to give a-priori assessment of protocols as well as to monitor and evaluate the progress, safety, and efficacy of clinical research. JORTC fulfills its tasks efficiently, intensively, and constantly and makes knowledge acquired through the operation open to the public.

Our main activities

(1)Providing support for protocol-writing related to cancer research and treatment
(2)Data management and statistical consideration to maintain / guarantee the quality of clinical trials related to cancer research and treatment
(3)Organizing and operating a third-party supervisory /management system to give a-priori assessment of protocols as well as to monitor and evaluate progress, safety, and efficacy of clinical trials related to cancer research and treatment
(4)Providing information about clinical trials related to cancer research and treatment

Steering Committee

The Chair

Dr. Satoru Iwase, MD, PhD.
Professor, Department of General Medicine (Palliative Care), Saitama Medicine University

Data Center

The Chair

Dr. Akira Inoue, MD, PhD.
Professor, Department of Palliative Medicine, Tohoku University School of Medicine

Advisory Board Members

■Advisory Board Member

Non Profit organization JORTC established the Advisory Board to evaluate the activities by the use of third party.

  • JORTC advisory board members are as follows;
  • Dr. Masashi Kato, MD, Chief, Medical Support and Partnership Division, Center for Cancer Control and Information Services, National Cancer Center
  • Dr. Yoshiyuki Kizawa, MD,PhD,FJSIM Designated Professor, Division of Palliative Medicine, Department of Internal Related. Kobe University Graduate School of Medicine
  • Dr. Mitsunori Miyashita, RN, PHN, PhD, Professor, Department of Palliative Nursing, Health Sciences, Graduate School of Medicine, Tohoku University
  • Dr. Yasuhito Uezono, MD, PhD Chief, Division of Cancer Pathophysiology, National Cancer Center Research Institute
  • Dr. Eduardo Bruera, MD, FT McGraw Chair in the Treatment of Cancer, Chair, Department of Palliative, Rehabilitation, & Integrative Medicine, UT MD Anderson Cancer Center
  • Dr. David Currow, B Med, MPH, FRACP Professor, Discipline of Palliative and Supportive Services, Flinders University Flinders Centre for Clinical Change, Flinders University Chief Investigator, PaCCSC (Palliative Care Clinical Studies Collaborative)

■Protocol Review Committee / Independent data monitoring committee

【Protocol Review Committee】
・reviews and evaluates the concept of study.
・approves the initiation of clinical research through reviewing the submitted protocol.

【Independent data monitoring committee】
・monitors the progress, safety, and efficacy of clinical studies throughout trials.
・reviews the adverse event reports.
・recommends the termination of the research or the protocol revision when it is necessary.
・reviews the revised protocol and approves it.

  • ●The chair
  • Dr. Yasushi Goto, MD., Department of Respiratory Medicine, National Cancer Center Hospital
  • ●The vice-chair
  • Dr. Teruhisa Azuma, MD., Division of General Medicine, Shirakawa Kosei General Hosptal / Associate Professor, Sirakawa Academy
  • Dr. Hiroto Ishiki, MD., Department of Palliative Medicine, The University of Tokyo, The Institute of Medical Science
  • ●The members
  • Ms. Kanako Azuma, Pharmacist., Department of Pharmacy, Tokyo Medical University Hospital
  • Dr. Aya Kuchiba, PhD., Center for Research Administration and Support, National Cancer Center
  • Dr. Nobuhiko Seki, MD, PhD., Clinical Professor, Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine
  • Dr. Masataka Taguri, PhD., Department of Biostatistics, Yokohama City University Medical Center
  • Ms. Ayano Takeuchi, Department of Preventive Medicine and Public Health, School of Medicine, Keio University
  • Ms. Makiko Mieno, MSc., Information Center, Jichi Medical University
  • Dr. Mitsunori Miyashita, RN, PHN, PhD., Professor, Department of Palliative Nursing, Tohoku University
  • Dr. Masanori Mori, MD., Department of Radiation Oncology/Palliative Care Team, Seirei Mikatahara General Hospital
  • Mr. Tetsuya Wako, Pharmacist., Department of Pharmacy, Nippon Medical School Hospital


    • Published:2012.12.13
      Last updated:2017.10.01

       
 

This site complies with the HONcode standard for trustworthy health information: verify here.